Shares of Cognyte Software program Ltd. (NASDAQ:CGNT – Get Free Report) gapped up earlier than the market opened on Friday following insider shopping for exercise. The inventory had beforehand closed at $6.31, however opened at $6.57. Cognyte Software program shares final traded at $6.99, with a quantity of 206,701 shares buying and selling palms.
Particularly, insider Topline Capital Administration, Ll purchased 416,040 shares of the enterprise’s inventory in a transaction that occurred on Thursday, September twelfth. The inventory was purchased at a median price of $6.30 per share, with a complete worth of $2,621,052.00. Following the completion of the acquisition, the insider now owns 9,020,184 shares of the corporate’s inventory, valued at roughly $56,827,159.20. The acquisition was disclosed in a submitting with the Securities & Trade Fee, which is accessible by the SEC web site. Additionally, main shareholder Topline Capital Companions, Lp bought 553,591 shares of the agency’s inventory in a transaction on Wednesday, September eleventh. The inventory was purchased at a median value of $6.31 per share, for a complete transaction of $3,493,159.21. Following the acquisition, the insider now owns 8,604,144 shares within the firm, valued at $54,292,148.64. The disclosure for this buy could be discovered right here.
Analyst Upgrades and Downgrades
A number of equities analysis analysts have lately issued reviews on the corporate. Needham & Firm LLC reaffirmed a “maintain” ranking on shares of Cognyte Software program in a report on Tuesday. StockNews.com downgraded Cognyte Software program from a “strong-buy” ranking to a “purchase” ranking in a analysis observe on Wednesday. Lastly, Wedbush elevated their goal value on Cognyte Software program from $8.00 to $9.00 and gave the corporate a “impartial” ranking in a analysis report on Thursday, June twentieth.
Get Our Newest Inventory Report on CGNT
Cognyte Software program Inventory Efficiency
The inventory has a market cap of $498.92 million, a P/E ratio of -40.82 and a beta of 1.74. The inventory’s fifty day shifting common is $7.39 and its 200 day shifting common is $7.49.
Cognyte Software program (NASDAQ:CGNT – Get Free Report) final posted its quarterly earnings knowledge on Tuesday, September tenth. The medical system firm reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.07. The enterprise had income of $84.40 million in the course of the quarter, in comparison with analyst estimates of $83.69 million. Cognyte Software program had a adverse return on fairness of two.56% and a adverse web margin of 1.35%. The corporate’s income for the quarter was up 9.5% on a year-over-year foundation. Throughout the identical interval final 12 months, the corporate earned ($0.11) EPS. Equities analysis analysts predict that Cognyte Software program Ltd. will submit -0.31 EPS for the present 12 months.
Institutional Traders Weigh In On Cognyte Software program
Hedge funds and different institutional traders have lately modified their holdings of the enterprise. Russell Investments Group Ltd. lifted its place in shares of Cognyte Software program by 8,624.3% in the course of the fourth quarter. Russell Investments Group Ltd. now owns 20,066 shares of the medical system firm’s inventory price $129,000 after buying a further 19,836 shares over the last quarter. Leap Monetary LLC elevated its place in shares of Cognyte Software program by 52.9% in the course of the fourth quarter. Leap Monetary LLC now owns 50,200 shares of the medical system firm’s inventory price $323,000 after buying a further 17,363 shares in the course of the interval. Hillsdale Funding Administration Inc. raised its stake in shares of Cognyte Software program by 32.8% in the course of the fourth quarter. Hillsdale Funding Administration Inc. now owns 28,339 shares of the medical system firm’s inventory valued at $182,000 after buying a further 7,000 shares within the final quarter. Trexquant Funding LP boosted its holdings in shares of Cognyte Software program by 43.0% within the fourth quarter. Trexquant Funding LP now owns 153,184 shares of the medical system firm’s inventory valued at $985,000 after buying a further 46,073 shares in the course of the interval. Lastly, Legacy Advisors LLC grew its stake in Cognyte Software program by 14.7% within the fourth quarter. Legacy Advisors LLC now owns 131,032 shares of the medical system firm’s inventory price $843,000 after buying a further 16,832 shares within the final quarter. 72.92% of the inventory is at present owned by hedge funds and different institutional traders.
Cognyte Software program Firm Profile
Cognyte Software program Ltd. offers an investigative analytics software program to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software program designed to assist governments and enterprises speed up and improve the effectiveness of investigations. The corporate presents community intelligence analytics, menace intelligence analytics, resolution intelligence analytics, and operational intelligence analytics options.
Learn Extra
Obtain Information & Scores for Cognyte Software program Every day – Enter your e mail tackle beneath to obtain a concise each day abstract of the newest information and analysts’ rankings for Cognyte Software program and associated corporations with MarketBeat.com’s FREE each day e mail e-newsletter.
